Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics

NIH Image to ImageJ: 25 years of image analysis

Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · see citing works

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237 · see citing works

The price of innovation: new estimates of drug development costs

DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265 · see citing works

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344 · see citing works

Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products

LUGO, T. G., Pendergast, A. M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,268 · see citing works

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention

Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., Flora, S. D., & Noonan, D. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp440 · Cited by 840 · see citing works

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

Dunnwald, L. K., Rossing, M. A., & Li, C. I. (2007) · Breast Cancer Research · doi:10.1186/bcr1639 · Cited by 787 · see citing works

Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications

Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N. C., Mandegar, M. A., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 527 · see citing works

Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies

Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487 · see citing works

A microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip

Sung, J. H., Kam, C., & Shuler, M. L. (2010) · Lab on a Chip · doi:10.1039/b917763a · Cited by 485 · see citing works

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

Cuzick, J. M., Šestak, I., Cawthorn, S., Hamed, H., Holli, K., Howell, A., & Forbes, J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71171-4 · Cited by 465 · see citing works

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

Cohen, M. H., Williams, G., Johnson, J. R., Duan, J. Z., Gobburu, J. V. S., Rahman, A., Benson, K. A., Leighton, J. K., Kim, S. K., Wood, R., et al. (2002) · PubMed · Cited by 465 · see citing works

Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs

Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442 · see citing works

Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity

Boelsterli, U. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00368-5 · Cited by 403 · see citing works

Key cost drivers of pharmaceutical clinical trials in the United States

Sertkaya, A., Wong, H.-H., Jessup, A., & Beleche, T. (2016) · Clinical Trials · doi:10.1177/1740774515625964 · Cited by 401 · see citing works

Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.

Coezy, E. D., Borgna, J., & Rochefort, H. (1982) · PubMed · Cited by 398 · see citing works

IN VITRO P-GLYCOPROTEIN INHIBITION ASSAYS FOR ASSESSMENT OF CLINICAL DRUG INTERACTION POTENTIAL OF NEW DRUG CANDIDATES: A RECOMMENDATION FOR PROBE SUBSTRATES

Rautio, J., Humphreys, J. E., Webster, L. O., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008615 · Cited by 260 · see citing works

Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling

Abaci, H. E., & Shuler, M. L. (2015) · Integrative Biology · doi:10.1039/c4ib00292j · Cited by 243 · see citing works

Diclofenac Toxicity to Hepatocytes: A Role for Drug Metabolism in Cell Toxicity

Bort, R., Ponsoda, X., Jover, R., Gómez‐Lechón, M. J., & Castell, J. V. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37925-x · Cited by 236 · see citing works

Design and demonstration of a pumpless 14 compartment microphysiological system

Miller, P. G., & Shuler, M. L. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.25989 · Cited by 235 · see citing works

Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system

Oleaga, C., Riu, A., Rothemund, S., Lavado, A., McAleer, C. W., Long, C. J., Persaud, K., Narasimhan, N. S., Tran, M., Roles, J., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.062 · Cited by 178 · see citing works

Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery

Forget, P., Bentin, C., Machiels, J.-P., Berlière, M., Coulie, P. G., & Kock, M. D. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aet464 · Cited by 160 · see citing works

Simultaneous electrical recording of cardiac electrophysiology and contraction on chip

Qian, F., Huang, C., Lin, Y.-D., Ivanovskaya, A. N., O’Hara, T., Booth, R., Creek, C. J., Enright, H. A., Soscia, D. A., Belle, A. M., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00210f · Cited by 128 · see citing works

Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase

Mughal, T. I. (2010) · Biologics · doi:10.2147/btt.s5775 · Cited by 119 · see citing works

Patterned cardiomyocytes on microelectrode arrays as a functional, high information content drug screening platform

Natarajan, A., Stancescu, M., Dhir, V., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.022 · Cited by 119 · see citing works

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

Pantziarka, P., Sukhatme, V. V., Bouche, G., Melhuis, L., & Sukhatme, V. P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.610 · Cited by 118 · see citing works

Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.

Reddel, R. R., Murphy, L. C., & Sutherland, R. L. (1983) · PubMed · Cited by 95 · see citing works

Rapidly rising clinical trial costs worry researchers

Collier, R. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.082041 · Cited by 95 · see citing works

DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES

Yan, Z., Li, J., Huebert, N. D., Caldwell, G. W., Du, Y., & Zhong, H. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003095 · Cited by 90 · see citing works

Measurement of Contractile Stress Generated by Cultured Rat Muscle on Silicon Cantilevers for Toxin Detection and Muscle Performance Enhancement

Wilson, K. A., Das, M., Wahl, K. J., Colton, R. J., & Hickman, J. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011042 · Cited by 82 · see citing works

Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancer.

Berg, S. L., Tolcher, A. W., O’Shaughnessy, J., et al. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.8.2039 · Cited by 74 · see citing works

The Antiestrogen Tamoxifen Blocks the Delayed Rectifier Potassium Current, IKr, in Rabbit Ventricular Myocytes

Liu, X. K., Katchman, A., Ebert, S. N., & Woosley, R. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37875-9 · Cited by 73 · see citing works

From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery

Pointon, A., Pilling, J. E., Dorval, T., Wang, Y., Archer, C. R., & Pollard, C. E. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw227 · Cited by 66 · see citing works

A Multifaceted Evaluation of Imatinib-induced Cardiotoxicity in the Rat

Herman, E. H., Knapton, A. D., Rosen, E. T., et al. (2011) · Toxicologic Pathology · doi:10.1177/0192623311419524 · Cited by 64 · see citing works

Long‐Term Electrical and Mechanical Function Monitoring of a Human‐on‐a‐Chip System

Oleaga, C., Lavado, A., Riu, A., Rothemund, S., Carmona‐Moran, C. A., Persaud, K., Yurko, A., Lear, J., Narasimhan, N. S., Long, C. J., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201805792 · Cited by 63 · see citing works

Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines

Albano, F., Arcucci, A., Granato, G., Romano, S., Montagnani, S., Vendittis, E. D., & Ruocco, M. R. (2012) · Biochimie · doi:10.1016/j.biochi.2012.12.012 · Cited by 62 · see citing works

A phenotypic in vitro model for the main determinants of human whole heart function

Stancescu, M., Molnár, P., McAleer, C. W., McLamb, W., Long, C. J., Oleaga, C., Prot, J. M., & Hickman, J. J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.035 · Cited by 60 · see citing works

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Henkes, M., van der Kuip, H., & Aulitzky, W. E. (2008) · PubMed Central · Cited by 49 · see citing works

Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40

Dhein, S., Polontchouk, L., Salameh, A., et al. (2002) · Biology of the Cell · doi:10.1016/s0248-4900(02)00018-7 · Cited by 49 · see citing works

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7

Lykkesfeldt, A. E., Larsen, J., Christensen, I. J., et al. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.113 · Cited by 47 · see citing works

Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy

Dnistrian, A. M., Schwartz, M. K., Greenberg, E. J., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90061-8 · Cited by 45 · see citing works

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

van der Kuip, H. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1527 · Cited by 36 · see citing works

An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities

Koci, B. J., Luerman, G. C., Duenbostell, A., et al. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.05.023 · Cited by 34 · see citing works

Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium Handling

Asp, M. L., Martindale, J. J., & Metzger, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078768 · Cited by 33 · see citing works

Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain

Jing-jing, D. U. A. N., Ma, J., Zhang, P., et al. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00562.x · Cited by 33 · see citing works

Cardiac Cell Culture Model As a Left Ventricle Mimic for Cardiac Tissue Generation

Nguyen, M.-D., Tinney, J. P., Yuan, F., et al. (2013) · Analytical Chemistry · doi:10.1021/ac401910d · Cited by 33 · see citing works

Correlation of embryonic skeletal muscle myotube physical characteristics with contractile force generation on an atomic force microscope-based bio-microelectromechanical systems device

Pirozzi, K., Long, C. J., McAleer, C. W., et al. (2013) · Applied Physics Letters · doi:10.1063/1.4817939 · Cited by 32 · see citing works

Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up

Rosell, J., Nordenskjöld, B. A., Bengtsson, N., Fornander, T., Hatschek, T., Lindman, H., Malmström, P.-O., Wallgren, A., Stål, O., & Carstensen, J. M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2457-6 · Cited by 27 · see citing works

Human‐on‐a‐Chip Systems: Long‐Term Electrical and Mechanical Function Monitoring of a Human‐on‐a‐Chip System (Adv. Funct. Mater. 8/2019)

Oleaga, C., Lavado, A., Riu, A., Rothemund, S., Carmona‐Moran, C. A., Persaud, K., Yurko, A., Lear, J., Narasimhan, N. S., Long, C. J., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201970049 · Cited by 27 · see citing works

Mechanistic investigation of adult myotube response to exercise and drug treatment in vitro using a multiplexed functional assay system

McAleer, C. W., Smith, A. S. T., Najjar, S. A., Pirozzi, K., Long, C. J., & Hickman, J. J. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00612.2014 · Cited by 22 · see citing works

Functional myotube formation from adult rat satellite cells in a defined serum‐free system

McAleer, C. W., Rumsey, J. W., Stancescu, M., & Hickman, J. J. (2015) · Biotechnology Progress · doi:10.1002/btpr.2063 · Cited by 19 · see citing works

Utilization of Microscale Silicon Cantilevers to Assess Cellular Contractile Function In Vitro

Smith, A. S. T., Long, C. J., McAleer, C. W., et al. (2014) · Journal of Visualized Experiments · doi:10.3791/51866 · Cited by 18 · see citing works

Contractile Force Readout of hESC-Cardiomyocytes

Oleaga, C., Legters, G., Bridges, L. R., Kumanchik, L., Martin, C., Cai, Y., Schnepper, M. T., McAleer, C. W., Long, C. J., & Hickman, J. J. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-6661-5_12 · Cited by 7 · see citing works

Human organs-on-chips for disease modelling, drug development and personalized medicine

Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589 · see citing works

A guide to the organ-on-a-chip

Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116 · see citing works

Organs-on-chips: into the next decade

Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029 · see citing works

A multi-organ chip with matured tissue niches linked by vascular flow

Ronaldson-Bouchard, K., Teles, D., Yeager, K., Tavakol, D. N., Zhao, Y., Chramiec, A., Tagore, S., Summers, M., Stylianos, S., Tamargo, M., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00882-6 · Cited by 512 · see citing works

Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery

Sharma, A., Sances, S., Workman, M. J., & Svendsen, C. N. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.02.011 · Cited by 296 · see citing works

Tumor-on-a-chip: from bioinspired design to biomedical application

Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246 · see citing works

Organs-on-a-chip models for biological research

Vunjak-Novakovic, G., Ronaldson-Bouchard, K., & Radisic, M. (2021) · Cell · doi:10.1016/j.cell.2021.08.005 · Cited by 248 · see citing works

Challenges and opportunities for the next generation of cardiovascular tissue engineering

Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., & Wu, J. C. (2022) · Nature Methods · doi:10.1038/s41592-022-01591-3 · Cited by 176 · see citing works

Microengineered Multi‐Organoid System from hiPSCs to Recapitulate Human Liver‐Islet Axis in Normal and Type 2 Diabetes

Tao, T., Deng, P., Wang, Y., Zhang, X., Guo, Y., Chen, W., & Qin, J. (2022) · Advanced Science · doi:10.1002/advs.202103495 · Cited by 178 · see citing works

Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases

Trapecar, M., Wogram, E., Svoboda, D., Communal, C., Omer, A., Lungjangwa, T., Sphabmixay, P., Velazquez, J., Schneider, K., Wright, C. W., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd1707 · Cited by 176 · see citing works

Human biomimetic liver microphysiology systems in drug development and precision medicine

Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117 · see citing works

Human microphysiological systems for drug development

Roth, A., & 2019, M.-W. B. (2021) · Science · doi:10.1126/science.abc3734 · Cited by 94 · see citing works

Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies

Rumsey, J. W., Lorance, C., Jackson, M., Sasserath, T., McAleer, C. W., Long, C. J., Goswami, A., Russo, M. A., Raja, S. M., Gable, K. L., et al. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200030 · Cited by 74 · see citing works

Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies

Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00531c · Cited by 58 · see citing works

Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS)

Malik, M., Yang, Y., Fathi, P., Mahler, G. J., & Esch, M. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721338 · Cited by 43 · see citing works

Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs

Wu, W., Anas, F., Koc, B., Tian, L., Hasselkus, R., Rezania, D., Sharareh, S., Farberov, L., Zlotnik, D., Alon, A., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118021 · Cited by 5 · see citing works

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide

Gjerde, J., Gandini, S., Guerrieri‐Gonzaga, A., Moi, L. L. H., Aristarco, V., Mellgren, G., DeCensi, A., & Lien, E. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2074-9 · Cited by 36 · see citing works

Sensitivity and insensitivity of breast cancer to tamoxifen

Gibson, D. F. C., Gottardis, M. M., & Jordan, V. C. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90417-j · Cited by 19 · see citing works

Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer

Mäenpää, J., Wiebe, V. J., Koester, S. J., et al. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00735926 · Cited by 11 · see citing works

Reduced tamoxifen accumulation is not associated with stimulated growth in tamoxifen resistance

Mäenpää, J., Wiebe, V. J., Wurz, G. T., et al. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686638 · Cited by 4 · see citing works

Effectiveness of steroid and imidazole drugs in inhibiting aromatase activity

Jawny, J., & EIERMANN, W. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)91524-x